Research and Development

Showing 15 posts of 9607 posts found.

mbeya_microscopy

Janssen in new collaboration to take on TB

December 3, 2015 Research and Development FIND, Janssen, antibiotic resistance, tuberculosis

Janssen has announced a new collaboration with the non-profit organisation FIND to step-up the fight against the public health threat …
zafgen_logo

Second patient dies in Zafgen obesity trial

December 3, 2015 Research and Development

Zafgen has announced the death of a second participant in a Phase III clinical trial of its obesity drug beloranib …
Victoza

Novo Nordisk buys Xoma diabetes program and scores trial successes

December 2, 2015 Research and Development, Sales and Marketing Novo Nordisk, Ryzodeg, SGLT2 inhibitors, Victoza, Xoma, diabetes

Novo Nordisk has announced its purchase of a type 2 diabetes diabetes program in a deal with biotech firm Xoma …
EU flags

Horizon receives European go-ahead for Ravicti

December 2, 2015 Research and Development, Sales and Marketing Horizon Pharma, Ravicti, horizon, orphan drug, rare disease, urea cycle disorders

The European Commission has approved Ravicti for rare urea cycle disorders.  Ravicti, (glycerol phenylbutyrate), is an oral liquid developed by Horizon …

Personalised care key to diabetes management, says NICE

December 2, 2015 Research and Development NICE, NICE guidelines, diabetes, type 2 diabetes

UK drugs regulator NICE has published updated guidelines on type 2 diabetes, saying that taking an individualised approach to care …
Xalkori

Pfizer lung cancer treatment gets expanded EU approval

December 1, 2015 Research and Development, Sales and Marketing NSCLC, Pfizer, Xalkori, crizotinib, lung cancer, non-small cell lung cancer

Pfizer UK has received European Commission approval for a label update to expand use of Xalkori (crizotinib) to first-line treatment …
janssen_scientists

J&J announces new partnerships in fight against HIV/AIDS

December 1, 2015 Research and Development AIDS, HIV, Janssen

Johnson &Johnson is entering four new public-private partnerships aimed at significantly reducing the burden of HIV incidence among young girls …
robert-horvitz_large_2

PureTech names Nobel Laureate among new members of scientific advisory board

December 1, 2015 Medical Communications, Research and Development PureTech Health, puretech

PureTech Health has compiled a scientific advisory board of distinguished scientists and physicians to expand its senior team.  The scientific …
Medicines Patent Pool

Collaboration between MPP and University of Liverpool targets HIV nanomedicines

December 1, 2015 Manufacturing and Production, Research and Development AIDS, HIV, Medicines Patent Pool, antiretrovirals, nanomedicines

The Medicines Patent Pool (MPP) and the University of Liverpool have agreed a partnership to use the university’s solid drug …

Laying bare the complexities of the pricing issue

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Drug pricing, access, affordability, cost of medicines

Richard Bergström, director general of the European Federation of Pharmaceutical Industry and Associations (EFPIA), on why full transparency in cost discussions …
robert_k

Ablynx appoints Robert Zeldin as new chief medical officer

November 30, 2015 Manufacturing and Production, Research and Development, Sales and Marketing Ablynx, Robert Zeldin

Ablynx has appointed Dr Robert Zeldin as chief medical officer (CMO) effective from 1 December 2015.  Dr Zeldin will lead …
ASH 2014 meeting

Bayer and Novartis to debut new data at ASH 2015

November 30, 2015 Research and Development, Sales and Marketing American Society of Hematology, Bayer, Conference, Novartis, ash, clinical trials, haematology, oncology

Pharma firms will present clinical trial results for the pipeline drugs they are pinning their 2016 hopes for success on, …
willy_simon

Willy Simon joins Tiziana as non-executive director

November 27, 2015 Research and Development Tiziana life sciences

Tiziana Life Sciences has appointed Willy Simon as a non-executive director who brings the benefit of a long and successful …
michael_linden_300dpi

Pfizer hires new lead for gene therapy research centre

November 26, 2015 Medical Communications, Research and Development Pfizer

Pfizer has hired Professor Michael Linden to lead its new gene therapy research centre in London.  Professor Michael Linden has …
praxbind

Boehringer’s Praxbind reversal agent wins EU approval

November 26, 2015 Medical Communications, Research and Development, Sales and Marketing

The European Commission has approved Boehringer Ingelheim’s Praxbind (idarucizumab)- a treatment to rapidly and specifically reverse the anticoagulant effects of …
The Gateway to Local Adoption Series

Latest content